Paul Biondi, Pioneering Medicines CEO

Flag­ship com­pa­ny teams up with Charles Riv­er for AI drug dis­cov­ery

One of Flag­ship’s en­ti­ties will be get­ting ac­cess to an AI drug dis­cov­ery tool from con­tract de­vel­op­er and man­u­fac­tur­er Charles Riv­er Lab­o­ra­to­ries.

On Thurs­day, Charles Riv­er an­nounced that Pi­o­neer­ing Med­i­cines, a unit of Flag­ship Pi­o­neer­ing, is seek­ing its ser­vices. The deal will see Pi­o­neer­ing Med­i­cines have ac­cess to Charles Riv­er’s and Va­lo Health’s AI drug dis­cov­ery plat­form, Log­i­ca. Pi­o­neer­ing Med­i­cines plans to use the plat­form across sev­er­al tar­gets to find and cre­ate small mol­e­cules that can be even­tu­al­ly turned in­to new ther­a­pies.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.